de la Cruz Jesús, Gómez-Herreros Fernando, Rodríguez-Galán Olga, Begley Victoria, de la Cruz Muñoz-Centeno María, Chávez Sebastián
Instituto de Biomedicina de Sevilla (IBiS), Hospital Virgen del Rocío-CSIC, Universidad de Sevilla, Seville, Spain.
Departamento de Genética, Universidad de Sevilla, Seville, Spain.
Curr Genet. 2018 Apr;64(2):393-404. doi: 10.1007/s00294-017-0764-x. Epub 2017 Oct 11.
Ribosome biogenesis is a crucial process for growth and constitutes the major consumer of cellular resources. This pathway is subjected to very stringent regulation to ensure correct ribosome manufacture with a wide variety of environmental and metabolic changes, and intracellular insults. Here we summarise our current knowledge on the regulation of ribosome biogenesis in Saccharomyces cerevisiae by particularly focusing on the feedback mechanisms that maintain ribosome homeostasis. Ribosome biogenesis in yeast is controlled mainly at the level of the production of both pre-rRNAs and ribosomal proteins through the transcriptional and post-transcriptional control of the TORC1 and protein kinase A signalling pathways. Pre-rRNA processing can occur before or after the 35S pre-rRNA transcript is completed; the switch between these two alternatives is regulated by growth conditions. The expression of both ribosomal proteins and the large family of transacting factors involved in ribosome biogenesis is co-regulated. Recently, it has been shown that the synthesis of rRNA and ribosomal proteins, but not of trans-factors, is coupled. Thus the so-called CURI complex sequesters specific transcription factor Ifh1 to repress ribosomal protein genes when rRNA transcription is impaired. We recently found that an analogue system should operate to control the expression of transacting factor genes in response to actual ribosome assembly performance. Regulation of ribosome biogenesis manages situations of imbalanced ribosome production or misassembled ribosomal precursors and subunits, which have been closely linked to distinct human diseases.
核糖体生物合成是细胞生长的关键过程,也是细胞资源的主要消耗途径。该途径受到非常严格的调控,以确保在各种环境和代谢变化以及细胞内损伤的情况下正确制造核糖体。在这里,我们总结了目前关于酿酒酵母核糖体生物合成调控的知识,特别关注维持核糖体稳态的反馈机制。酵母中的核糖体生物合成主要通过TORC1和蛋白激酶A信号通路的转录和转录后控制,在pre-rRNA和核糖体蛋白的产生水平上进行调控。pre-rRNA加工可以在35S pre-rRNA转录本完成之前或之后发生;这两种方式之间的转换受生长条件的调节。核糖体蛋白和参与核糖体生物合成的大量反式作用因子的表达是共同调控的。最近的研究表明,rRNA和核糖体蛋白的合成是偶联的,但反式作用因子的合成并非如此。因此,当rRNA转录受损时,所谓的CURI复合物会隔离特定的转录因子Ifh1,以抑制核糖体蛋白基因的表达。我们最近发现,应该存在一个类似的系统来响应实际的核糖体组装性能,控制反式作用因子基因的表达。核糖体生物合成的调控可处理核糖体产生失衡或核糖体前体和亚基组装错误的情况,这些情况与多种人类疾病密切相关。